[TNXP] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
01-Apr-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 0.19%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 7,768 0 0 0 0 0 0 -
PBT -116,658 -110,218 -92,287 -50,463 -28,618 -26,089 -21,123 32.93%
Tax -0 4,786 -75 -75 -236 233 -70 -
NP -116,658 -116,877 -92,287 -52,174 -31,092 -29,355 -21,123 32.93%
Tax Rate - - - - - - - -
Total Cost 124,426 116,877 92,287 52,174 31,092 29,355 21,123 34.36%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -1,501.78 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -219.09 -640.26 -1,620.86 -3,530.04 0.00 0.00 0.00 -
EPS Diluted -219.09 -640.26 -1,620.86 -3,530.04 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.